The Russian pharmaceutical company “Nanolek” was founded in 2011. It specializes in the production of import-substituting medicines for the prevention and treatment of socially significant diseases.

In 2020, the company was recognized as a backbone enterprise of the Russian economy. In 2021, “Nanolek” was included in RBC's rating — “50 Fastest Growing Companies in Russia”.

Company

“Nanolek” has accumulated a unique experience in technology transfer:

more than 10 innovative drugs have been localized at the plant in the Kirov region in partnership with big pharma companies — world industry leaders.

900

employees

20% of which are engaged solely in quality control

33

drugs

in the portfolio. 20 more drugs are under development

11.5

billion rubles

have been invested in the company since 2011

0.5

million rubles

taxes paid to in the Kirov region over the past 3 years

NANOLEK IS A MEMBER OF ASSOCIATIONS
NANOLEK IS THE LEADER OF RATINGS

The mission

Protect people's lives and health by producing the world's best technologies, made available to everyone

Strategy

From the localization of the drugs of global pharmaceutical companies, to the biotech production of a full cycle and the development of innovative medicines “from scratch”

Team

Mikhail Nekrasov

Mikhail Nekrasov

CEO, Chairman of the Board
Maxim Stetsyuk

Maxim Stetsyuk

First Deputy General Director, Director of the Vaccines Division, Member of the Management Board
Artem An

Artem An

Deputy General Director for Strategic Development, Director of the Specialized Products Division, Member of the Management Board
Evgeny Barinov

Evgeny Barinov

Deputy General Director for Investments and Digital Technologies, Member of the Management Board
Maria Voronina

Maria Voronina

Deputy General Director for Human Resources and Administrative Affairs, Member of the Management Board
Denis Dugin

Denis Dugin

Director of the Biomedical Complex, Deputy General Director for Operations and Partner Relations, Member of the Management Board
Svetlana Zakirova

Svetlana Zakirova

Deputy General Director for Development and Research, Member of the Management Board
Marina Mazurevskaya

Marina Mazurevskaya

Deputy General Director for Legal Affairs and Work with Public Authorities, Member of the Management Board
Elena Stukun

Elena Stukun

Deputy General Director for Commercial Activities, Member of the Management Board
Alexey Pavlov

Alexey Pavlov

Director of Quality Management Department / Authorized Person
Alexey Ryzhiy

Alexey Ryzhiy

Director of Information Technology Department
 Sergey Tolstobrov

Sergey Tolstobrov

Director of the Department for the Development of Economic Territories

Partners

Our rule, without exception: All “Nanolek” partners are leaders in their field with impeccable reputations.

*GMP (Good Manufacturing Practice) —rules that establish requirements for the organization of production and quality control of drugs for medical and veterinary use.

**ISO 9001 — this standard is based on a number of quality management principles, such as strong customer orientation, management involvement and motivation, process approach and continuous improvement. The application of ISO 9001 helps to ensure that customers consistently receive high-quality products and services.